2-(3-(phenylsulfonyl)ureido)-N-propyl-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxamide

ID: ALA574651

PubChem CID: 45112560

Max Phase: Preclinical

Molecular Formula: C20H25N3O4S2

Molecular Weight: 435.57

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCNC(=O)c1c(NC(=O)NS(=O)(=O)c2ccccc2)sc2c1CCCCC2

Standard InChI:  InChI=1S/C20H25N3O4S2/c1-2-13-21-18(24)17-15-11-7-4-8-12-16(15)28-19(17)22-20(25)23-29(26,27)14-9-5-3-6-10-14/h3,5-6,9-10H,2,4,7-8,11-13H2,1H3,(H,21,24)(H2,22,23,25)

Standard InChI Key:  OUDXNOQMKPCNTJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
    1.7400  -18.6318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4846  -18.2854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5472  -19.4359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0561  -20.0870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8821  -20.0929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2239  -18.6556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4043  -19.4557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2211  -19.5315    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.5455  -18.7780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9296  -18.2368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3697  -18.7749    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7856  -19.4873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6106  -19.4834    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3765  -20.2038    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0265  -20.1959    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.8515  -20.1920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2656  -20.9065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0898  -20.9029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4997  -20.1860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0794  -19.4711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2566  -19.4782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3245  -20.6359    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4333  -20.9083    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9083  -17.4121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6119  -16.9813    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1835  -17.0181    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4799  -17.4489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7550  -17.0549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0514  -17.4857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 14  2  0
  1  3  1  0
 13 15  1  0
  1  2  1  0
 15 16  1  0
  3  4  1  0
 16 17  2  0
  2  6  1  0
 17 18  1  0
  7  8  1  0
 18 19  2  0
  8  9  1  0
 19 20  1  0
  9 10  2  0
 20 21  2  0
 21 16  1  0
 10  6  1  0
 15 22  2  0
  7  5  1  0
 15 23  2  0
  9 11  1  0
 10 24  1  0
  4  5  1  0
 24 25  2  0
 11 12  1  0
 24 26  1  0
  6  7  2  0
 26 27  1  0
 12 13  1  0
 27 28  1  0
 28 29  1  0
M  END

Associated Targets(Human)

EKVX (44102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leukemia cell (223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NSCLC (640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Melanoma cell (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC 2998 (41480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-257 (46019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 435.57Molecular Weight (Monoisotopic): 435.1286AlogP: 3.67#Rotatable Bonds: 6
Polar Surface Area: 104.37Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.57CX Basic pKa: CX LogP: 5.05CX LogD: 4.11
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.60Np Likeness Score: -1.93

References

1. El-Sherbeny MA, Abdel-Aziz AA, Ahmed MA..  (2010)  Synthesis and antitumor evaluation of novel diarylsulfonylurea derivatives: molecular modeling applications.,  45  (2): [PMID:19939520] [10.1016/j.ejmech.2009.11.014]

Source